المؤلفون: Olivier J. van Not, Thijs T. Wind, Rawa K. Ismail, Arkajyoti Bhattacharya, Mathilde Jalving, Christian U. Blank, Maureen J. B. Aarts, Franchette W. P. J. van den Berkmortel, Marye J. Boers-Sonderen, Alfonsus J. M. van den Eertwegh, Jan Willem B. de Groot, John B. Haanen, Ellen Kapiteijn, Manja Bloem, Djura Piersma, Rozemarijn S. van Rijn, Marion Stevense-den Boer, Astrid A. M. van der Veldt, Gerard Vreugdenhil, Michel W. J. M. Wouters, Willeke A. M. Blokx, Karijn P. M. Suijkerbuijk, Rudolf S. N. Fehrmann, Geke A. P. Hospers

المصدر: Cancers; Volume 15; Issue 11; Pages: 2922

مصطلحات موضوعية: advanced melanoma, immunotherapy, brain metastases, survival tree

وصف الملف: application/pdf

العلاقة: Cancer Immunology and Immunotherapy; https://dx.doi.org/10.3390/cancers15112922Test

الإتاحة: https://doi.org/10.3390/cancers15112922Test

المؤلفون: Jesper van Breeschoten, Alfons J.M. van den Eertwegh, Doranne L. Hilarius, John B. Haanen, Christian U. Blank, Maureen J.B. Aarts, Franchette W.P.J. van den Berkmortel, Jan Willem B. de Groot, Geke A.P. Hospers, Ellen Kapiteijn, Djura Piersma, Rozemarijn S. van Rijn, Marion A. Stevense-den Boer, Astrid A.M. van der Veldt, Gerard Vreugdenhil, Marye J. Boers-Sonderen, Damjan Manevski, Karijn P.M. Suijkerbuijk, Michel W.J.M. Wouters, Liesbeth C. de Wreede

المساهمون: RS: GROW - R3 - Innovative Cancer Diagnostics & Therapy, Interne Geneeskunde, MUMC+: MA Medische Oncologie (9), Guided Treatment in Optimal Selected Cancer Patients (GUTS), Internal medicine, Medical oncology, AII - Cancer immunology, CCA - Cancer Treatment and quality of life, CCA - Cancer biology and immunology, Obstetrics and gynaecology, Amsterdam Reproduction & Development (AR&D), Medical Oncology

المصدر: European Journal of Cancer, 182, pp. 132-143
European Journal of Cancer, 182, 132-143. ELSEVIER SCI LTD
European Journal of Cancer, 182, 132-143. Pergamon
van Breeschoten, J, van den Eertwegh, A J M, Hilarius, D L, Haanen, J B, Blank, C U, Aarts, M J B, van den Berkmortel, F W P J, de Groot, J W B, Hospers, G A P, Kapiteijn, E, Piersma, D, van Rijn, R S, Stevense-den Boer, M A, van der Veldt, A A M, Vreugdenhil, G, Boers-Sonderen, M J, Manevski, D, Suijkerbuijk, K P M, Wouters, M W J M & de Wreede, L C 2023, ' Population mortality in advanced melanoma patients with and without response and progression; data from the Dutch Melanoma Treatment Registry ', European Journal of Cancer, vol. 182, pp. 132-143 . https://doi.org/10.1016/j.ejca.2023.01.006Test
European Journal of Cancer, 182, 132-143
European Journal of Cancer, 182, 132-143. Elsevier Ltd.

مصطلحات موضوعية: Cancer Research, Multistate model, PHASE-3, Population mortality, Response status, MULTICENTER, Relative survival, Advanced melanoma, OPEN-LABEL, COMPETING RISKS, VEMURAFENIB, Healthcare improvement science Radboud Institute for Health Sciences [Radboudumc 18], All institutes and research themes of the Radboud University Medical Center, Oncology, SDG 3 - Good Health and Well-being, Older patients, SURVIVAL, METASTATIC MELANOMA

وصف الملف: application/pdf

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::afee38642ca1159b695777f346821b37Test
http://www.scopus.com/inward/record.url?scp=85147863592&partnerID=8YFLogxKTest

المؤلفون: Jesper van Breeschoten, Alfonsus J. M. van den Eertwegh, Liesbeth C. de Wreede, Doranne L. Hilarius, Erik W. van Zwet, John B. Haanen, Christian U. Blank, Maureen J. B. Aarts, Franchette W. P. J. van den Berkmortel, Jan Willem B. de Groot, Geke A. P. Hospers, Ellen Kapiteijn, Djura Piersma, Rozemarijn S. van Rijn, Marion A. M. Stevense-den Boer, Astrid A. M. van der Veldt, Gerard Vreugdenhil, Marye J. Boers-Sonderen, Karijn P. M. Suijkerbuijk, Michel W. J. M. Wouters

المصدر: Cancers; Volume 13; Issue 20; Pages: 5077

مصطلحات موضوعية: advanced melanoma, survival, center variation

وصف الملف: application/pdf

العلاقة: https://dx.doi.org/10.3390/cancers13205077Test

الإتاحة: https://doi.org/10.3390/cancers13205077Test

المؤلفون: Monique K. van der Kooij, Marjolein J.A.L. Wetzels, Maureen J.B. Aarts, Franchette W.P.J. van den Berkmortel, Christian U. Blank, Marye J. Boers-Sonderen, Miranda P. Dierselhuis, Jan Willem B. de Groot, Geke A.P. Hospers, Djura Piersma, Rozemarijn S. van Rijn, Karijn P.M. Suijkerbuijk, Albert J. ten Tije, Astrid A.M. van der Veldt, Gerard Vreugdenhil, Michel W.J.M. Wouters, John B.A.G. Haanen, Alfonsus J.M. van den Eertwegh, Esther Bastiaannet, Ellen Kapiteijn

المصدر: Cancers; Volume 12; Issue 8; Pages: 2072

مصطلحات موضوعية: advanced melanoma, adolescents, young adults, AYA, BRAF mutation, checkpoint inhibitors, targeted therapy, prospective nation-wide data, outcome research, clinical audit

وصف الملف: application/pdf

العلاقة: Cancer Therapy; https://dx.doi.org/10.3390/cancers12082072Test

الإتاحة: https://doi.org/10.3390/cancers12082072Test

المؤلفون: Bart Neyns, Christian U. Blank, Michal Lotem, Mark R. Middleton, J.-J. Grob, Melanie A. Leiby, Antoni Ribas, C. Robert, Jacob Schachter, Céleste Lebbé, Euan Walpole, Matteo S. Carlino, Neil Steven, Nageatte Ibrahim, Peter Mohr, A. Arance, Paul Lorigan, Mario Sznol, Erin Jensen, Georgina V. Long, Laurent Mortier

المساهمون: Faculty of Law and Criminology, Medical Oncology, Clinical sciences, Laboratory of Molecular and Medical Oncology, Faculty of Arts and Philosophy

المصدر: Long, G V, Arance, A, Mortier, L, Lorigan, P, Blank, C, Mohr, P, Schachter, J, Grob, J-J, Lotem, M, Middleton, M R, Neyns, B, Steven, N, Ribas, A, Walpole, E, Carlino, M S, Lebbe, C, Sznol, M, Jensen, E, Leiby, M A, Ibrahim, N & Robert, C 2022, ' Antitumor activity of ipilimumab or BRAF ± MEK inhibition after pembrolizumab treatment in patients with advanced melanoma : analysis from KEYNOTE-006 ', Annals of oncology : official journal of the European Society for Medical Oncology, vol. 33, no. 2, pp. 204-215 . https://doi.org/10.1016/j.annonc.2021.10.010Test

مصطلحات موضوعية: Proto-Oncogene Proteins B-raf, advanced melanoma, Oncology, BRAF inhibition, medicine.medical_specialty, Ipilimumab, Pembrolizumab, Antibodies, Monoclonal, Humanized, Internal medicine, medicine, Humans, In patient, ipilimumab, Melanoma, Complete response, Advanced melanoma, Mitogen-Activated Protein Kinase Kinases, Antitumor activity, Manchester Cancer Research Centre, business.industry, ResearchInstitutes_Networks_Beacons/mcrc, Hematology, medicine.disease, MEK inhibition, pembrolizumab, business, Progressive disease, medicine.drug

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3ae40264769d12ae7ca2fde50f109b8fTest
https://doi.org/10.1016/j.annonc.2021.10.010Test

المؤلفون: Christian U. Blank, John B. A. G. Haanen, Doranne L. Hilarius, Michel W. J. M. Wouters, Willeke A. M. Blokx, Franchette W P J van den Berkmortel, Ellen Kapiteijn, Rawa K. Ismail, Geke A. P. Hospers, Jesper van Breeschoten, Alfonsus J. M. van den Eertwegh, Rozemarijn S. van Rijn, Jan Willem B. de Groot, Maureen J.B. Aarts, D Piersma, Astrid A M van der Veldt, G. Vreugdenhil, Marion A. M. Stevense-den Boer, Marye Boers-Sonderen, Karijn P M Suijkerbuijk, Olivier J. van Not, Melissa M. De Meza

المساهمون: RS: GROW - R3 - Innovative Cancer Diagnostics & Therapy, Interne Geneeskunde, MUMC+: MA Medische Oncologie (9), Medical Oncology, Radiology & Nuclear Medicine, Guided Treatment in Optimal Selected Cancer Patients (GUTS), Internal medicine, Medical oncology, AII - Cancer immunology, CCA - Cancer Treatment and quality of life, Obstetrics and gynaecology, Amsterdam Reproduction & Development (AR&D)

المصدر: International Journal of Cancer, 150(5), 816-824. Wiley
van Not, O J, van Breeschoten, J, van den Eertwegh, A J M, Hilarius, D L, de Meza, M M, Haanen, J B, Blank, C U, Aarts, M J B, van den Berkmortel, F W P J, de Groot, J W B, Hospers, G A P, Ismail, R K, Kapiteijn, E, Piersma, D, van Rijn, R S, Stevense-den Boer, M A M, van der Veldt, A A M, Vreugdenhil, G, Boers-Sonderen, M J, Blokx, W A M, Suijkerbuijk, K P M & Wouters, M W J M 2022, ' The unfavorable effects of COVID-19 on Dutch advanced melanoma care ', International Journal of Cancer, vol. 150, no. 5, pp. 816-824 . https://doi.org/10.1002/ijc.33833Test
International Journal of Cancer, 150, 816-824
International Journal of Cancer, 150, 5, pp. 816-824
International Journal of Cancer, 150(5), 816-824. Wiley-Liss Inc.
International Journal of Cancer, 150(5), 816-824. WILEY
International Journal of Cancer

مصطلحات موضوعية: Adult, Male, advanced melanoma, Cancer Research, Pediatrics, medicine.medical_specialty, Skin Neoplasms, Coronavirus disease 2019 (COVID-19), IMPACT, nationwide registry, Medical care, Systemic therapy, Healthcare improvement science Radboud Institute for Health Sciences [Radboudumc 18], systemic therapy, SDG 3 - Good Health and Well-being, COVID‐19, Humans, Medicine, Stage IIIC, Cancer Therapy and Prevention, Melanoma, Aged, Netherlands, Advanced melanoma, Aged, 80 and over, Control period, Performance status, SARS-CoV-2, business.industry, COVID-19, Middle Aged, medicine.disease, clinical outcomes, Oncology, Female, business

وصف الملف: application/pdf

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6999d1436b905ac42aa992a91b031b28Test
https://hdl.handle.net/2066/244556Test

المؤلفون: Djura Piersma, Marye J Boers-Sonderen, Geke A. P. Hospers, Karijn P M Suijkerbuijk, Christian U. Blank, Roos S. van Rijn, Astrid A M van der Veldt, Jan-Willem B de Groot, Ellen Kapiteijn, Franchette W P J van den Berkmortel, Alfonsus J. M. van den Eertwegh, Jesper van Breeschoten, Doranne L. Hilarius, Bert-Jan J. ten Tije, Michel W.J.M. Wouters, Art Vreugdenhil, John B. A. G. Haanen, Maureen J.B. Aarts, Willeke A. M. Blokx

المصدر: Br J Cancer

مصطلحات موضوعية: Oncology, medicine.medical_specialty, Cancer Research, business.industry, First line, Anti pd 1, Mutant, Correction, Cancer, medicine.disease, 03 medical and health sciences, 0302 clinical medicine, 030220 oncology & carcinogenesis, Internal medicine, Medicine, business, Survival analysis, Advanced melanoma

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ec07bf292a49af842f52b06a5d9be0e0Test
https://doi.org/10.1038/s41416-022-01772-zTest

المؤلفون: Alfonsus J. M. van den Eertwegh, Michel W.J.M. Wouters, Roos S. van Rijn, John B. A. G. Haanen, Maureen J.B. Aarts, Bert-Jan J. ten Tije, Karijn P M Suijkerbuijk, Christian U. Blank, Jesper van Breeschoten, Geke A. P. Hospers, Jan-Willem B de Groot, Franchette W P J van den Berkmortel, Ellen Kapiteijn, Doranne L. Hilarius, Marye J Boers-Sonderen, Djura Piersma, Art Vreugdenhil, Astrid A M van der Veldt, Willeke A. M. Blokx

المساهمون: VU University medical center, Obstetrics and gynaecology, Internal medicine, AII - Cancer immunology, CCA - Cancer Treatment and quality of life, Radiology & Nuclear Medicine, RS: GROW - R3 - Innovative Cancer Diagnostics & Therapy, Interne Geneeskunde, MUMC+: MA Medische Oncologie (9)

المصدر: British Journal of Cancer
British Journal of Cancer, 124(7), 1222-1230. Nature Publishing Group
British Journal of Cancer, 124, 7, pp. 1222-1230
British Journal of Cancer, 124, 1222-1230
van Breeschoten, J, Wouters, M W J M, Hilarius, D L, Haanen, J B, Blank, C U, Aarts, M J B, van den Berkmortel, F W P J, de Groot, J-W B, Hospers, G A P, Kapiteijn, E, Piersma, D, van Rijn, R S, Suijkerbuijk, K P M, Blokx, W A M, Tije, B-J J T, Veldt, A A M V D, Vreugdenhil, A, Boers-Sonderen, M J & van den Eertwegh, A J M 2021, ' First-line BRAF/MEK inhibitors versus anti-PD-1 monotherapy in BRAFV600-mutant advanced melanoma patients: a propensity-matched survival analysis ', British Journal of Cancer, vol. 124, no. 7, pp. 1222-1230 . https://doi.org/10.1038/s41416-020-01229-1Test
British Journal of Cancer, 124(7), 1222-1230. SPRINGERNATURE

مصطلحات موضوعية: Oncology, Cancer Research, medicine.medical_specialty, PHASE-3, First line, Systemic therapy, VEMURAFENIB, Article, Healthcare improvement science Radboud Institute for Health Sciences [Radboudumc 18], POOLED ANALYSIS, Matched cohort, SDG 3 - Good Health and Well-being, Internal medicine, Medicine, METASTATIC MELANOMA, neoplasms, Melanoma, Survival analysis, Advanced melanoma, nivolumab, business.industry, IPILIMUMAB, Anti pd 1, medicine.disease, DABRAFENIB, Propensity score matching, pembrolizumab, business

وصف الملف: application/pdf

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::836391be4c5b8d33487fc86cac6f6337Test
https://doi.org/10.1038/s41416-020-01229-1Test

المؤلفون: Jan Willem B. de Groot, Djura Piersma, John B. A. G. Haanen, Astrid A M van der Veldt, Alfonsus J. M. van den Eertwegh, Christian U. Blank, Gerard Vreugdenhil, Ellen Kapiteijn, Esther Bastiaannet, Monique K van der Kooij, Miranda P Dierselhuis, Marye J Boers-Sonderen, Karijn P M Suijkerbuijk, Albert J. ten Tije, Franchette W P J van den Berkmortel, Marjolein J A L Wetzels, Maureen J.B. Aarts, Rozemarijn S. van Rijn, Michel W.J.M. Wouters, Geke A. P. Hospers

المساهمون: CCA - Cancer Treatment and quality of life, Medical oncology, RS: GROW - R3 - Innovative Cancer Diagnostics & Therapy, Interne Geneeskunde, MUMC+: MA Medische Oncologie (9), Medical Oncology, Guided Treatment in Optimal Selected Cancer Patients (GUTS)

المصدر: van der Kooij, M K, Wetzels, M J A L, Aarts, M J B, van den Berkmortel, F W P J, Blank, C U, Boers-Sonderen, M J, Dierselhuis, M P, de Groot, J W B, Hospers, G A P, Piersma, D, van Rijn, R S, Suijkerbuijk, K P M, Ten Tije, A J, van der Veldt, A A M, Vreugdenhil, G, Wouters, M W J M, Haanen, J B A G, van den Eertwegh, A J M, Bastiaannet, E & Kapiteijn, E 2020, ' Age Does Matter in Adolescents and Young Adults versus Older Adults with Advanced Melanoma; A National Cohort Study Comparing Tumor Characteristics, Treatment Pattern, Toxicity and Response ', Cancers, vol. 12, no. 8, 2072, pp. 1-15 . https://doi.org/10.3390/cancers12082072Test
Cancers, 12(8):2072, 1-15. Multidisciplinary Digital Publishing Institute (MDPI)
Cancers, 12, 8
Cancers, 12
Cancers
Cancers, 12(8):2072. Multidisciplinary Digital Publishing Institute (MDPI)
Cancers, 12(8):2072, 1-15. MDPI AG
Cancers, Vol 12, Iss 2072, p 2072 (2020)
Cancers, 12(8). MDPI

مصطلحات موضوعية: Neuroblastoma RAS viral oncogene homolog, advanced melanoma, young adults, Cancer Research, medicine.medical_specialty, AYA, microbiome, open-label, lcsh:RC254-282, survival, Article, Healthcare improvement science Radboud Institute for Health Sciences [Radboudumc 18], 030207 dermatology & venereal diseases, 03 medical and health sciences, 0302 clinical medicine, Internal medicine, Medicine, METASTATIC MELANOMA, Cumulative incidence, adolescents, Young adult, ipilimumab, Adverse effect, PEMBROLIZUMAB, risk, nivolumab, business.industry, MUTATIONS, prospective nation-wide data, Melanoma, Hazard ratio, clinical audit, Cancer, lcsh:Neoplasms. Tumors. Oncology. Including cancer and carcinogens, medicine.disease, targeted therapy, humanities, Clinical trial, BRAF mutation, Oncology, 030220 oncology & carcinogenesis, choice chemotherapy, outcome research, business, checkpoint inhibitors

وصف الملف: application/pdf

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::de7e43ad335ec2975ce6222cf027b69dTest
https://doi.org/10.3390/cancers12082072Test

المؤلفون: Michel W.J.M. Wouters, Marion Stevense, Ellen Kapiteijn, Christian U. Blank, Karijn P M Suijkerbuijk, Astrid Aplonia Maria Van Der Veldt, Geke A. P. Hospers, Djura Piersma, Rozemarijn S. van Rijn, Alfonsus J. M. van den Eertwegh, Gerard Vreugdenhil, Maureen J.B. Aarts, Liesbeth C. de Wreede, Jesper van Breeschoten, Erik W. van Zwet, John B. A. G. Haanen, Jan Willem B. de Groot, Franchette W P J van den Berkmortel, Marye Boers-Sonderen, Doranne L. Hilarius

المساهمون: Guided Treatment in Optimal Selected Cancer Patients (GUTS), Internal medicine, Medical oncology, AII - Cancer immunology, CCA - Cancer Treatment and quality of life, Obstetrics and gynaecology, Medical Oncology, Radiology & Nuclear Medicine, RS: GROW - R3 - Innovative Cancer Diagnostics & Therapy, Interne Geneeskunde, MUMC+: MA Medische Oncologie (9)

المصدر: Cancers, 13(20):5077. MDPI AG
Cancers, 13, 20
van Breeschoten, J, van den Eertwegh, A J M, de Wreede, L C, Hilarius, D L, van Zwet, E W, Haanen, J B, Blank, C U, Aarts, M J B, van den Berkmortel, F W P J, de Groot, J W B, Hospers, G A P, Kapiteijn, E, Piersma, D, van Rijn, R S, Stevense-den Boer, M A M, van der Veldt, A A M, Vreugdenhil, G, Boers-sonderen, M J, Suijkerbuijk, K P M & Wouters, M W J M 2021, ' Hospital variation in cancer treatments and survival outcomes of advanced melanoma patients : Nationwide quality assurance in the netherlands ', Cancers, vol. 13, no. 20, 5077 . https://doi.org/10.3390/cancers13205077Test
Cancers, 13(20):5077. Multidisciplinary Digital Publishing Institute (MDPI)
Cancers, Vol 13, Iss 5077, p 5077 (2021)
Cancers, 13(20). MDPI
Cancers
Volume 13
Issue 20
Cancers, 13

مصطلحات موضوعية: Oncology, advanced melanoma, Cancer Research, medicine.medical_specialty, Metastatic melanoma, IMPACT, MULTICENTER, survival, VEMURAFENIB, Article, Healthcare improvement science Radboud Institute for Health Sciences [Radboudumc 18], POOLED ANALYSIS, All institutes and research themes of the Radboud University Medical Center, SDG 3 - Good Health and Well-being, Internal medicine, medicine, METASTATIC MELANOMA, Quality of care, RC254-282, Advanced melanoma, business.industry, center variation, Melanoma, Significant difference, Neoplasms. Tumors. Oncology. Including cancer and carcinogens, Cancer, medicine.disease, Random effects model, DABRAFENIB, Stage iv melanoma, business, Quality assurance

وصف الملف: application/pdf

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d369fca07c88bdc71e6f5d5567757c91Test
https://hdl.handle.net/11370/144a687b-1f76-44fd-acca-1d9813cd82c3Test